Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
Clinical trial NCT00735072 · COMPLETED
Trial details
- NCT number
- NCT00735072
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2010-04-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.